Institutional investors purchased a net $2.3 million shares of SPPI during the quarter ended March 2017, and now own 74.36% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 874.9 Thousand shares of Spectrum Pharmaceuticals ...
SSGA FUNDS MANAGEMENT, INC. Bought 733.7 Thousand shares of Spectrum Pharmaceuticals ...